BIOPIX-T announced that the portable molecular diagnostic platform “PEBBLE” as well as the compatible diagnostic test for coronavirus, are now commercially available upon notification to the EOF (Greek National Organization for Medicines).
This device is based on research conducted by BIOPIX-T executives at the Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology – Hellas (IMBB-FORTH) in Crete and perfected within the company, which is based in the Science and Technology Park of Crete (STEP-C).
George Papadakis who leads the company said: “I am very proud of the BIOPIX-T team which has managed, with a lot of hard work and in a really short time, to bring a technology out of the lab and offer it as a functional and reliable product in the market.”
For more, please visit the following link
https://biopix-t.com/news/biopix-t-launches-its-portable-molecular-diagnostic-device-pebble-with-the-covid19-test-for-the-point-of-care/